Wenger Plattner regularly handles corporate and commercial issues for pharma clients, including the financing of research projects. In Basel, practice head Tobias Meili is well-versed in corporate governance issues and M&A within the life sciences space, while Carlo Conti combines his broad experience of administrative and pharma law to advise on market authorisations. Daniel Zimmerli joined the firm in March 2024 from Walder Wyss Ltd., bringing his expertise in hospital planning matters.
Legal 500 Editorial commentary
- Profile
Testimonials
Collated independently by Legal 500 research team.
‘Excellent know-how of the industry and strategic consulting on how to proceed on various topics.’
‘Deep knowledge of Swiss healthcare laws. Broad network within the industry.’
‘Tobias Meili and André Berne are great communicators who know how to approach critical issues with other parties and moderate the legal questions.’
Key clients
- enovis
- Swiss Rockets AG
- Bachem AG
- SWICA
- Mathys AG Bettlach
- Bio-Techne
- Labor Team w
- Zurzach Care AG
- Schweizerische Diabetes-Stiftung
- Casavita Stiftung
Work highlights
Advising Bachem in its further growth for the planning and building of its new manufacturing site at Sisslerfeld with an investment volume of more than CHF 750 million.
Advised Sana Kliniken AG on transparency and disclosure obligations as a medical products broker and supply chain network coordinator.
Advising the Swiss Diabetes Foundation regarding the reassessment and reorganisation of the financial structure.
Lawyers
Practice head
Tobias Meili
Other key lawyers
Carlo Conti; André Berne; Daniel Zimmerli